Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Could the radon in your home raise your brain cancer risk? A new study of nearly 160,000 women found a possible association between higher residential radon levels and CNS cancer incidence — but the findings varied widely depending on which radon dataset was used, leaving experts divided on what the data actually prove.
A new observational cohort study published in Neuroepidemiology analyzed data from 159,391 Women's Health Initiative (WHI) participants over an average of 17.7 years, finding that women living in areas with higher estimated residential radon concentrations had a generally greater risk of developing malignant CNS cancers. The biological rationale is plausible — radon's radioactive decay products emit alpha particles that can damage DNA, and some decay products have even been detected in human brain tissue post-mortem.
But the findings come with a major caveat: the association was inconsistent across four different radon exposure datasets. Some models showed hazard ratios as high as 1.49–1.56 for the highest radon tertile, while others (notably USGS and EPA data) showed no statistically significant risk at all. Epidemiologist Gideon Meyerowitz-Katz called the results "almost entirely dependent on the statistical model," noting that one figure even showed a decline in CNS risk at higher radon levels.
Key Takeaways:
Why it matters: Radon is already the #1 cause of lung cancer among nonsmokers. If future, better-powered studies confirm a CNS cancer link, it could strengthen the case for broader residential radon testing and mitigation — but for now, the evidence remains inconclusive.
